Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2049261699;61700;61701 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
N2AB1885156776;56777;56778 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
N2A1792453995;53996;53997 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
N2B1142734504;34505;34506 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
Novex-11155234879;34880;34881 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
Novex-21161935080;35081;35082 chr2:178590251;178590250;178590249chr2:179454978;179454977;179454976
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Ig-121
  • Domain position: 14
  • Structural Position: 25
  • Q(SASA): 0.1929
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/K rs2154184267 None 0.826 N 0.345 0.313 0.208000267992 gnomAD-3.1.2 6.58E-06 None None None None I None 0 0 0 0 0 None 0 3.16456E-03 0 0 0
Q/K rs2154184267 None 0.826 N 0.345 0.313 0.208000267992 gnomAD-4.0.0 3.15482E-06 None None None None I None 0 0 None 0 0 None 0 1.69607E-04 3.43116E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.3655 ambiguous 0.3894 ambiguous -0.32 Destabilizing 0.927 D 0.327 neutral None None None None I
Q/C 0.8064 likely_pathogenic 0.8362 pathogenic 0.196 Stabilizing 0.999 D 0.482 neutral None None None None I
Q/D 0.4844 ambiguous 0.4902 ambiguous -0.004 Destabilizing 0.969 D 0.295 neutral None None None None I
Q/E 0.121 likely_benign 0.116 benign -0.017 Destabilizing 0.826 D 0.381 neutral N 0.42840301 None None I
Q/F 0.8859 likely_pathogenic 0.9 pathogenic -0.437 Destabilizing 0.991 D 0.46 neutral None None None None I
Q/G 0.3966 ambiguous 0.3967 ambiguous -0.539 Destabilizing 0.969 D 0.389 neutral None None None None I
Q/H 0.3226 likely_benign 0.3409 ambiguous -0.47 Destabilizing 0.015 N 0.193 neutral N 0.444223398 None None I
Q/I 0.7919 likely_pathogenic 0.8291 pathogenic 0.176 Stabilizing 0.997 D 0.461 neutral None None None None I
Q/K 0.1965 likely_benign 0.1833 benign 0.031 Stabilizing 0.826 D 0.345 neutral N 0.462230369 None None I
Q/L 0.365 ambiguous 0.3768 ambiguous 0.176 Stabilizing 0.959 D 0.383 neutral N 0.504906498 None None I
Q/M 0.4926 ambiguous 0.5212 ambiguous 0.531 Stabilizing 0.997 D 0.33 neutral None None None None I
Q/N 0.2746 likely_benign 0.3077 benign -0.328 Destabilizing 0.939 D 0.288 neutral None None None None I
Q/P 0.9104 likely_pathogenic 0.9237 pathogenic 0.04 Stabilizing 0.996 D 0.345 neutral N 0.45926374 None None I
Q/R 0.2938 likely_benign 0.2685 benign 0.165 Stabilizing 0.92 D 0.331 neutral N 0.471620643 None None I
Q/S 0.3215 likely_benign 0.3442 ambiguous -0.347 Destabilizing 0.969 D 0.285 neutral None None None None I
Q/T 0.3383 likely_benign 0.3714 ambiguous -0.193 Destabilizing 0.969 D 0.383 neutral None None None None I
Q/V 0.5817 likely_pathogenic 0.6195 pathogenic 0.04 Stabilizing 0.99 D 0.407 neutral None None None None I
Q/W 0.8719 likely_pathogenic 0.8825 pathogenic -0.37 Destabilizing 0.999 D 0.467 neutral None None None None I
Q/Y 0.6996 likely_pathogenic 0.7227 pathogenic -0.13 Destabilizing 0.939 D 0.363 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.